Unani Formulation in the management of Urinary Incontinence
- Conditions
- stress Urinary incontinence
- Registration Number
- CTRI/2018/04/012977
- Lead Sponsor
- Luqman Unani Medical College Hospital and Research Centre
- Brief Summary
Patients meeting all the inclusion criteria will be randomly allocated either to test (n=20) or control group (n=20) after taking their consent. Patients will be blinded for the study. In test group polyherbal unani formulation will be given for 60 days and in the control group placebo will be given for the same duration. Kiegel’s exrecise will be advised to both the groups. Subjective parameters will be assessed on each visit and objective parameters will be assessed before and after treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Female
- Target Recruitment
- 40
Patients of SUI clinically assessed will be included in the study after obtaining their voluntary consent.
Pregnant and lactating women Women on OCPs Patients with 3rd and 4th degree genital prolapse history of systemic illnesses, endocrinal diseases and malignancies history ofany pharmacological intervention within 3 months and have had surgical intervention for SUI.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in ICIQ-SF score. 60days Reduction in the number of incontinent episode assessed by bladder diary. 60days
- Secondary Outcome Measures
Name Time Method Pelvic floor muscle strength assessed by Modified Oxford Grading Scale. Stress test
Trial Locations
- Locations (1)
Luqman Unani Medical College Hospital and Research Centre
🇮🇳Bijapur, KARNATAKA, India
Luqman Unani Medical College Hospital and Research Centre🇮🇳Bijapur, KARNATAKA, IndiaDr Mariyam RoqaiyaPrincipal investigator9739814729drjuveriya10@gmail.com